Version 1
: Received: 31 May 2024 / Approved: 3 June 2024 / Online: 3 June 2024 (07:39:46 CEST)
How to cite:
Khaspekov, L. G.; Illarioshkin, S. N. Outcomes and Outlooks of Therapeutic Application of Modulators of Endogenous Cannabinoid System in Parkinson's Disease. Preprints2024, 2024060037. https://doi.org/10.20944/preprints202406.0037.v1
Khaspekov, L. G.; Illarioshkin, S. N. Outcomes and Outlooks of Therapeutic Application of Modulators of Endogenous Cannabinoid System in Parkinson's Disease. Preprints 2024, 2024060037. https://doi.org/10.20944/preprints202406.0037.v1
Khaspekov, L. G.; Illarioshkin, S. N. Outcomes and Outlooks of Therapeutic Application of Modulators of Endogenous Cannabinoid System in Parkinson's Disease. Preprints2024, 2024060037. https://doi.org/10.20944/preprints202406.0037.v1
APA Style
Khaspekov, L. G., & Illarioshkin, S. N. (2024). Outcomes and Outlooks of Therapeutic Application of Modulators of Endogenous Cannabinoid System in Parkinson's Disease. Preprints. https://doi.org/10.20944/preprints202406.0037.v1
Chicago/Turabian Style
Khaspekov, L. G. and Sergey N. Illarioshkin. 2024 "Outcomes and Outlooks of Therapeutic Application of Modulators of Endogenous Cannabinoid System in Parkinson's Disease" Preprints. https://doi.org/10.20944/preprints202406.0037.v1
Abstract
Recent studies have shown that the endogenous cannabinoid system (ECS) of the brain is essentially involved in the pathogenesis of Parkinson's disease (PD), influencing its symptoms by regulating the level of endogenous cannabinoids and altering the activation of cannabinoid receptors (CBR). Therefore, modulation of ECS with new drugs developed for this purpose may prove to be a promising strategy in the treatment of PD. However, fine regulation of ECS is quite a challenge due to the functional diversity of CBR in the basal ganglia. Our review analyses the effects of ECS modulators on experimental PD models and in patients with PD, as well as presents the outlooks for the development of new cannabinoid drugs for the treatment of motor and non-motor symptoms in PD.
Medicine and Pharmacology, Neuroscience and Neurology
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.